The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.
Showing results 1 - 10 of 23
Thailand National Guidelines on HIV/AIDS Treatment & Prevention, 2021-22
These guidelines have been developed for healthcare providers to diagnose, prevent, care for, and treat those who have acquired HIV. These guidelines also contain necessary updates since previous guidelines.
India National Technical Guidelines for PrEP, 2022
India’s National Technical Guidelines for PrEP provide information on key considerations for prospective PrEP users, consent, how to initiate on PrEP, adherence, evaluation needs, and more.
Injectable PrEP Factsheet for MSM Advocates and Community Members in the Asia-Pacific Region
This factsheet raises awareness of injectable cabotegravir (CAB) for PrEP and describes actions community members can take to advocate for the approval and availability of CAB for PrEP in their country in the Asia Pacific region. This factsheet is designed for gay, bisexual, and other men who have sex with men advocates and community members-…
Injectable PrEP Factsheet for Transgender and Gender-Nonbinary Advocates and Community Members in the Asia-Pacific Region
This factsheet raises awareness of injectable cabotegravir (CAB) for PrEP and describes actions community members can take to advocate for the approval and availability of CAB for PrEP in their country in the Asia Pacific region. This factsheet is designed for transgender and non-binary advocates and community members- another for gay, bisexual, and other men…
Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
This journal article from Antimicrobial Agents and Chemo Therapy shares an extended report on HIV infections that occurred up to 1 year after study unblinding (18 in the CAB arm and 34 in the TDF-FTC arm).
Monitoring & Evaluation
National Strategic Plan for HIV/AIDS and STI, 2017 – 24
In 2016, India committed to the goal of ending AIDS as a public health threat by 2030. This national strategic plan provides methods and information on how the country intends on changing its healthcare approach to reach their goal.
Acceptability of PrEP among MSM and Transgender Communities: Qualitative findings from two metropolitan cities in India
This article from PLOS One explores the acceptability of PrEP as a HIV prevention tool with gay and bisexual men who have sex with men and trans individuals in Bengaluru and Delhi, India.
Demand Creation/Marketing, Research, Service Delivery
Transgender Women in HPTN 083: An evaluation of safety, efficacy, and gender affirming hormonal therapy interactions with long-acting cabotegravir
This poster from AIDS 2022 presents an analysis of results from the HPTN 083 study, looking at the impact of feminizing gender affirming hormones on cabotegravir (CAB) for PrEP pharmacokinetics.
Asia Region ROP, 2022
The goal of 2022 Regional Operational Plan for the Asia Region is to maintain progress from 2021 in key areas related to health promotion such as refining efforts to eliminate policy barriers, insitutionalizing client- centered services, helping the countries under PEPFAR in the Asia Region achieve 95-95-95, and spotlighting HIV prevention and treatment access for…
Sri Lanka National HIV/STI Strategic Plan, 2018-22
A list of priority activities to be conducted over the next five years and a framework of indicators to guide and monitor the response is provided in this plan. The activities have been costed and budget is shown under each strategic direction and as well as under different cost categories. The Government of Sri Lanka…